Market Snapshot

BSE Sensex: 77763.91 0.34%
BSE 500: 36431.45 0.15%
BSE 200: 11317.86 0.17%
BSE 100: 25809.44 0.24%
BSE BANKEX: 65450.3 -0.09%
BSE IT: 26730.46 1.55%
Nifty 50: 24270.85 0.39%
Nifty 500: 23301.15 0.16%
Nifty 200: 13992.05 0.19%
Nifty 100: 25301.9 0.28%
Nifty Midcap 100: 62190.3 -0.19%
Nifty Small 100: 19175.1 0.04%
Nifty IT: 27439.4 1.76%
Nifty PSU Bank: 8407.6 -1.54%

News:

Karur Vysya Banks total busine...
Yes Bank reports 18% YoY rise ...
Godrej Consumer Products expec...
Quality Power arm Mehru Electr...
Bandhan Banks total deposits r...

Aspira Pathlab & Diagnostics Ltd Share Price – BSE
Healthcare, Small Cap

Invest

03 Jul 2026 | 03:59 PM

128.90

-2.60 (-1.98%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

131.34%

Return (1Y)

Beaten BSE Sensex by 137.91%
More Volatile

3.87%

Standard Deviation (1Y)

Higher than BSE Sensex by 3.03%
Not so consistent

6/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

136

49

News & Announcements

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.69 crore in the March 2026 quarter

41 days ago

Aspira Pathlab & Diagnostics to announce Quarterly Result
47 days ago

Aspira Pathlab & Diagnostics to announce Quarterly Result

19 - May - 2026 12:00 | 47 days ago

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 23 May 2026.
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 1.56 crore in the December 2025 quarter
144 days ago

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 1.56 crore in the December 2025 quarter

11 - Feb - 2026 12:00 | 144 days ago

Net loss of Aspira Pathlab & Diagnostics reported to Rs 1.56 crore in the quarter ended December 2025 as against net profit of Rs 0.38 crore during the previous quarter ended December 2024. Sales declined 5.36% to Rs 5.12 crore in the quarter ended December 2025 as against Rs 5.41 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 5.12 5.41 -5

OPM % -23.63 14.23 -

PBDT -1.18 0.77 PL

PBT -1.56 0.38 PL

NP -1.56 0.38 PL

Powered by Capital Market - Live News
Aspira Pathlab & Diagnostics to declare Quarterly Results
150 days ago

Aspira Pathlab & Diagnostics to declare Quarterly Results

05 - Feb - 2026 12:00 | 150 days ago

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 10 February 2026.
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

Aspira Pathlab & Diagnostics Ltd has been the 3rd best in 3 years performance among stocks in Healthcare Sector
Aspira Pathlab & Diagnostics Ltd is trading very close to its All time High
Aspira Pathlab & Diagnostics Ltd is trading very close to its 52 Week High
Aspira Pathlab & Diagnostics Ltd has the Lowesr P/E ratio according to FY 202603 data among stocks in Healthcare Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60